Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses.

Humans BCG Vaccine Interleukin 1 Receptor Antagonist Protein / genetics Interleukin-1 / genetics Metabolic Networks and Pathways Proteomics Tuberculosis / drug therapy
IL-1 IL-1ra immunometabolism systems immunology tuberculosis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 15 03 2022
accepted: 12 09 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 4 1 2023
Statut: epublish

Résumé

Tuberculosis (TB) remains a major public health problem and we lack a comprehensive understanding of how

Identifiants

DOI: 10.3389/fimmu.2022.897193 PMID: 36591308 PMC: PMC9795069
pubmed: 36591308
doi: 10.3389/fimmu.2022.897193
pmc: PMC9795069
doi:

Substances chimiques

BCG Vaccine 0
Interleukin 1 Receptor Antagonist Protein 0
Interleukin-1 0
IL1RN protein, human 0
IL1A protein, human 0
IL1B protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

897193

Informations de copyright

Copyright © 2022 Llibre, Smith, Rouilly, Musvosvi, Nemes, Posseme, Mabwe, Charbit, Mbandi, Filander, Africa, Saint-André, Bondet, Bost, Mulenga, Bilek, Albert, Scriba and Duffy.

Déclaration de conflit d'intérêts

MLA is a current employee of HIBIO. VR was employed by DATACTIX. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

PLoS Pathog. 2018 Jan 25;14(1):e1006874
pubmed: 29370315
Front Immunol. 2020 May 12;11:891
pubmed: 32477361
Eur Respir J. 2014 May;43(5):1472-86
pubmed: 24311770
J Immunol. 2010 Jul 15;185(2):929-42
pubmed: 20554962
Clin Microbiol Rev. 2018 Jul 18;31(4):
pubmed: 30021818
Nat Microbiol. 2019 Dec;4(12):2128-2135
pubmed: 31611644
Nat Rev Dis Primers. 2016 Oct 27;2:16076
pubmed: 27784885
Front Cell Infect Microbiol. 2019 Aug 22;9:296
pubmed: 31508378
J Virol. 2005 May;79(10):6441-8
pubmed: 15858027
Nat Immunol. 2014 Nov;15(11):1026-37
pubmed: 25263125
Nat Commun. 2018 Dec 6;9(1):5208
pubmed: 30523338
J Invest Dermatol. 2005 Jun;124(6):1267-74
pubmed: 15955103
PPAR Res. 2012;2012:383829
pubmed: 22851964
Sci Transl Med. 2018 Mar 14;10(432):
pubmed: 29540618
Lancet Infect Dis. 2009 Dec;9(12):737-46
pubmed: 19926034
Immunity. 1995 Jun;2(6):561-72
pubmed: 7540941
PLoS Med. 2019 Apr 23;16(4):e1002786
pubmed: 31013272
BMC Med. 2016 Mar 23;14:37
pubmed: 27005907
Tuberculosis (Edinb). 2018 Jul;111:170-177
pubmed: 30029904
Cell Res. 2010 Feb;20(2):124-37
pubmed: 20101262
J Immunol. 2016 Dec 15;197(12):4727-4735
pubmed: 27913648
J Leukoc Biol. 2019 Feb;105(2):297-306
pubmed: 30211958
J Immunol. 1989 Sep 15;143(6):1851-8
pubmed: 2528582
J Immunol. 1993 May 15;150(10):4687-92
pubmed: 8482853
Cytokine. 2002 Jun 21;18(6):320-8
pubmed: 12160520
Front Immunol. 2017 Jul 13;8:796
pubmed: 28751891
Tuberculosis (Edinb). 2018 Jan;108:124-126
pubmed: 29523312
Nature. 2018 Aug;560(7720):644-648
pubmed: 30135583
Microbiol Mol Biol Rev. 2013 Dec;77(4):608-27
pubmed: 24296574
PLoS One. 2012;7(10):e48102
pubmed: 23118933
J Immunol. 2014 Oct 1;193(7):3600-12
pubmed: 25187652
J Immunol. 2008 Jul 1;181(1):235-42
pubmed: 18566389
J Immunol. 2015 Jan 15;194(2):491-7
pubmed: 25556251
Cell Rep. 2016 Sep 6;16(10):2777-2791
pubmed: 27568558
J Infect. 2020 Jul;81(1):57-71
pubmed: 32330526
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):E488-E497
pubmed: 29282317
Clin Infect Dis. 2021 Nov 2;73(9):e3398-e3408
pubmed: 33059361
Immunity. 2014 Mar 20;40(3):436-50
pubmed: 24656047
J Exp Med. 1993 Dec 1;178(6):2249-54
pubmed: 7504064
Cell. 1998 Apr 17;93(2):229-40
pubmed: 9568715
Immunity. 2015 Jun 16;42(6):991-1004
pubmed: 26084020
J Exp Med. 1993 Dec 1;178(6):2243-7
pubmed: 8245795
Immunity. 2011 Dec 23;35(6):1023-34
pubmed: 22195750
Semin Immunopathol. 2016 Jul;38(4):517-34
pubmed: 27001429
Immunol Rev. 2015 Mar;264(1):88-102
pubmed: 25703554
Nat Rev Immunol. 2016 Sep;16(9):553-65
pubmed: 27396447
J Immunol. 2007 Jul 15;179(2):1178-89
pubmed: 17617611
Cell Host Microbe. 2008 Apr 17;3(4):224-32
pubmed: 18407066
Sci Rep. 2015 Nov 20;5:16882
pubmed: 26586179
Best Pract Res Clin Endocrinol Metab. 2007 Dec;21(4):687-710
pubmed: 18054742
Nat Commun. 2016 Sep 27;7:12874
pubmed: 27670879
J Invest Dermatol. 1993 Jul;101(1):79-85
pubmed: 8331299
Front Immunol. 2018 Jun 21;9:1427
pubmed: 29977244
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Prostaglandins Other Lipid Mediat. 2006 Sep;80(3-4):165-74
pubmed: 16939881
Front Immunol. 2019 Mar 22;10:527
pubmed: 30967866
J Immunol. 2007 Sep 1;179(5):3119-25
pubmed: 17709526
Cell Res. 2012 Apr;22(4):746-56
pubmed: 21986665
J Immunol. 2010 Apr 1;184(7):3326-30
pubmed: 20200276
Nat Med. 2013 May;19(5):557-66
pubmed: 23652116
J Immunol. 2012 Jun 1;188(11):5593-603
pubmed: 22544925
J Exp Med. 2017 May 1;214(5):1547-1555
pubmed: 28420733
Cytokine. 2017 Nov;99:194-202
pubmed: 28712670
J Exp Med. 2018 May 7;215(5):1273-1285
pubmed: 29666166
J Biol Chem. 2016 Jul 15;291(29):15108-18
pubmed: 27226602
Nat Immunol. 2018 Nov;19(11):1159-1168
pubmed: 30333612

Auteurs

Alba Llibre (A)

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.

Nikaïa Smith (N)

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.

Vincent Rouilly (V)

DATACTIX, Paris, France.

Munyaradzi Musvosvi (M)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Elisa Nemes (E)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Céline Posseme (C)

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.

Simbarashe Mabwe (S)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Bruno Charbit (B)

Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, Université Paris Cité, Paris, France.

Stanley Kimbung Mbandi (SK)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Elizabeth Filander (E)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Hadn Africa (H)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Violaine Saint-André (V)

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Bioinformatics and Biostatistics HUB, Computational Biology Department, Institut Pasteur, Université Paris Cité, Paris, France.

Vincent Bondet (V)

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.

Pierre Bost (P)

Sorbonne Université, Complexité du vivant, Paris, France.
Systems Biology Group, Computational Biology Department, Institut Pasteur, Université Paris Cité, Paris, France.

Humphrey Mulenga (H)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Nicole Bilek (N)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Matthew L Albert (ML)

HIBIO, San Francisco, CA, United States.

Thomas J Scriba (TJ)

South African Tuberculosis Vaccine Initiative (SATVI), Division of Immunology, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Darragh Duffy (D)

Translational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, Université Paris Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Tuberculosis alters immune-metabolic pathways...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antibactériens › Vaccins antituberculeux › Vaccin BCG › Tuberculosis alters immune-metabolic pathways...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Antagoniste du récepteur à l'interleukine-1 › Tuberculosis alters immune-metabolic pathways...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Monokines › Interleukine-1 › Tuberculosis alters immune-metabolic pathways...
questionsmedicales.fr › Métabolisme › Voies et réseaux métaboliques › Tuberculosis alters immune-metabolic pathways...
questionsmedicales.fr › Disciplines des sciences naturelles › Chimie › Biochimie › Protéomique › Tuberculosis alters immune-metabolic pathways...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à Actinomycetales › Infections à Mycobacterium › Tuberculose › Tuberculosis alters immune-metabolic pathways...